PT  - JOURNAL ARTICLE
AU  - A. ZABLOW
AU  - M. ADAMS
AU  - C. GREGORI
AU  - J. L. BREEN
AU  - L. J. SANFILIPPO
TI  - Stage II adenocarcinoma of the endometrium treated by two standard regimens of combined preoperative irradiation and surgery
AID  - 10.1046/j.1525-1438.1994.04040265.x
DP  - 1994 Jul 01
TA  - International Journal of Gynecologic Cancer
PG  - 265--271
VI  - 4
IP  - 4
4099  - http://ijgc.bmj.com/content/4/4/265.short
4100  - http://ijgc.bmj.com/content/4/4/265.full
SO  - Int J Gynecol Cancer1994 Jul 01; 4
AB  - We retrospectively analyzed 77 patients with stage II endometrial carcinoma treated with standard regimens of preoperative radiotherapy (RT) and surgery (S). The age range was 31–74 years with a median of 56.3 years. Thirty-three patients received 40 Gy whole pelvis RT followed by either radical or modified radical hysterectomy. Forty-four patients received 50 Gy whole pelvis RT and sequential intrauterine and intravaginal cesium-137 brachytherapy followed by a simple hysterectomy. Median follow-up was 111 months. No patient was lost to follow-up. The overall 5-year actuarial survival was 78%. There was no significant difference between the two treatment groups. Several prognostic variables were analyzed. Those with histologic grade I and II had 5-year survival of 89% and 83%, respectively, compared to 62% for grade III (P =0.045). The 5-year survival for microscopic cervical involvement was 87% compared to 59% for gross involvement (P = 0.008). Patients with negative or microscopic residual tumor in the surgical specimen and those with negative lymph nodes had less risk of treatment failure. Local failure occurred in only 9%. Major complications (3%) were seen only in the radical surgery group. Combined preoperative RT and S provide high cure rates with minimal complications for patients with stage II endometrial carcinoma. Patients with adverse prognostic factors are candidates for trials of more aggressive local and systemic therapy.